Effect of curcumin in hearing loss and diabetes

Effects Of Curcumin In Sensorineural Hearing Loss In Patients Having Type 2 Diabetes Mellitus Single Blind Randomized Control Trial - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070625

Enrollment

Registered

2024-07-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: curcumin: curcumin in dose of 500mg thrice a day for 8 weeks Intervention2: CURCUMIN: 44 PATIENTS HAVING SNHL WITH TYPE 2 DIABETES MELLITUS WILL BE GIVEN 500MG CURCUMIN TDS FOR 8 WEEKS

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WITH DIABETES MELLITUS TYPE 2 AGE 30-60 PATIENTS WITH DOCUMENTED SNHL.

Exclusion criteria

Exclusion criteria: patients on the insulin therapy HBA1C more than 11% H/O middle ear disease or surgery h/o conductive hearing loss

Design outcomes

Primary

Measure	Time frame
1.Magnitude of SNHL in type 2 DM 2.Evaluate potential of curcumin as therapeutic agent for treating of diabetes associated SNHL 3.Delineate risk factors associated with SNHL among type 2 DM population and serve as a cornerstone in formulating screening guidelinesfor SNHL in type 2 DMTimepoint: 8 weeks	—

Secondary

Measure	Time frame
1.changes in HBA1c 2 changes in lipid profile 3.changes in MDA ,SOD,HSCRPTimepoint: 8weeks	—

Countries

India

Contacts

Public ContactDr Nusrat Nabi

jamia hamdard

dr.seema.monga@gmail.com8470040230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026